FOOD AND DRUG ADMINISTRATION ISSUES NOTICE: ADVANCING THE DEVELOPMENT OF INTERCHANGEABLE PRODUCTS: IDENTIFYING FUTURE NEEDS; PUBLIC WORKSHOP; REQUEST FOR COMMENTS

WASHINGTON, Aug. 15 -- Food and Drug Administration has issued a notice called: Advancing the Development of Interchangeable Products: Identifying Future Needs; Public Workshop; Request for Comments.

The notice was published in the Federal Register on Aug. 15 by Grace R. Graham, Deputy Commissioner for Policy, Legislation, and International Affairs.

Summary: The Food and Drug Administration (FDA, the Agency, or we) is announcing the following public workshop entitled "Advancing the Development of Interchangeable Products: Identifying Future Needs." The purpose of the public workshop is to address a commitment FDA made in the Biosimilar User Fee Act (BsUFA) reauthorization commitment letter for fiscal years (FYs) 2023 through 2027 (BsUFA I...